NCT07081945View on ClinicalTrials.gov

hAM for Inferior RRD

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Rhegmatogenous Retinal Detachment
Interventions
DEVICE

hAM

The hAM stands for human amniotic membrane, which was used to seal inferior retinal breaks after complete vitrectomy.

Trial Locations (1)

200031

RECRUITING

EyeEntFudan, Shanghai

All Listed Sponsors
lead

Eye & ENT Hospital of Fudan University

OTHER

NCT07081945 - hAM for Inferior RRD | Biotech Hunter | Biotech Hunter